The mechanism of the MAPK/ERK1/2 signaling pathway, with regard to activation in RCC, has now been reported [10], which regulates the progression of RCC by promoting proliferation, migration, and invasion [11,12,13]. Here, MAPK3 is linked to renal cell adenocarcinoma.